Mohamad Mohty Mohamad Mohty, MD, PhD, Professor of Hematology and Head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and Sorbonne University in Paris, France. He also leads a translational research team (INSERM team) at the Saint-Antoine Research Center, Paris, France. Prof. Mohty is the Chairman of the Acute Leukemia Working Party […]
How to Get Published: a Few Tips Read More »
Joshua Fein Dr. Joshua Fein is a fellow in hematology and medical oncology at Weill Cornell Medicine / NewYork Presbyterian hospital in New York City and has been engaged in research in hematopoietic cell transplantation and acute leukemia over the past decade. Dr. Fein’s has focused on applying computational tools, and statistical and machine learning
CD47 : From bench to bedside? Read More »
Jorge Castillo Dr. Castillo is an Associate Professor at Harvard Medical School and serves as the Clinical Director of the Bing Center for Waldenström Macroglobulinemia at the Dana-Farber Cancer Institute. Dr. Castillo is also the principal investigator in a series of innovative clinical trials evaluating highly effective non-chemotherapeutic approaches for patients with Waldenström macroglobulinemia. Dr.
Management of Waldenström’s Disease: An Update Read More »
Ali Bazarbachi Ali Bazarbachi MD, PhD is a Professor of Medicine (Hematology and Oncology), Anatomy, Cell Biology and Physiological Sciences. Founding Director of the bone marrow transplantation program at the American University of Beirut Medical Center.
Transplant Indications in Lymphoma: Where Are We? Read More »
All those who wish to attend the IACH Congress online can do so here and complete the full CME-accredited program course.
IACH 2025 Scientific Program course Read More »
Sébastien Anguille Prof. Anguille is hematologist and Head of the Division of Hematology at the Antwerp University Hospital since January 2022. He is a passionate researcher at the University of Antwerp who combines clinical work with scientific research. His research focuses on the development of new treatments for hematological diseases, such as AML, with a main
CAR T-cells for AML: Where do we stand? Read More »
Dan Wolff Prof. Wolff is Chair of the multidisciplinary GVHD Center of the University Hospital Regensburg, Germany. His work focuses on pathophysiology and treatment of chronic GVHD and he is a member of the steering committee of the NIH Consensus on cGVHD 2020 and chair of the German-Austrian-Swiss GVHD consortium.
Management of chronic GVHD – Monday, December 16, 2024 Read More »
Florent Malard Florent Malard is Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University. Florent Malard was a visiting investigator at the Memorial Sloan Kettering Cancer Center in New-York, USA from 2015-2016. He is now a researcher at the Saint-Antoine research Center in Paris and his research focus on Graft-versus-Host disease, microbiota and immunological
Diagnosis and management of acute GVHD – Monday, November 4, 2024 Read More »
Steven Pavletic Dr. Pavletic is a an expert in chronic graft-versus-host disease (cGVHD); his clinical studies focus on improving treatment for patients with cGVHD. Dr. Pavletic has led national and international efforts to develop consensus guidelines for cGVHD clinical trials. Currently, he directs the NIH cGVHD Study Group and the NIH Myeloid Malignancies Clinical Program,
Diagnosis and grading of chronic GVHD – Monday, November 25, 2024 Read More »
Rafael Duarte Rafael F. Duarte, MD, PhD, FRCP, Head of Department of Hematology at Hospital Puerta de Hierro in Madrid. He is a HSCT physician and scientist with particular interest in infective and non-infective complications of transplant and cellular therapies, past-chair of the EBMT Transplant Complications Working Party, past-Secretary of the Society and EBMT Congress
Early transplant complications: a focus on VOD diagnosis Read More »
